Pictet Asset Management (UK)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$261M Buy
1,293,145
+50,686
+4% +$10.2M 0.28% 106
2021
Q1
$267M Sell
1,242,459
-123,410
-9% -$26.5M 0.32% 88
2020
Q4
$323M Buy
1,365,869
+385,022
+39% +$91M 0.42% 61
2020
Q3
$267M Sell
980,847
-151,466
-13% -$41.2M 0.42% 62
2020
Q2
$329M Buy
1,132,313
+206,126
+22% +$59.8M 0.57% 38
2020
Q1
$220M Sell
926,187
-97,204
-9% -$23.1M 0.47% 52
2019
Q4
$224M Sell
1,023,391
-146,453
-13% -$32.1M 0.4% 68
2019
Q3
$198M Buy
1,169,844
+33,218
+3% +$5.63M 0.42% 63
2019
Q2
$208M Buy
1,136,626
+82,061
+8% +$15M 0.45% 55
2019
Q1
$194M Buy
1,054,565
+58,181
+6% +$10.7M 0.43% 59
2018
Q4
$165K Sell
996,384
-99,381
-9% -$16.5K 0.41% 66
2018
Q3
$211M Sell
1,095,765
-117,986
-10% -$22.7M 0.45% 58
2018
Q2
$206M Buy
1,213,751
+10,233
+0.9% +$1.74M 0.49% 50
2018
Q1
$196M Buy
1,203,518
+6,167
+0.5% +$1.01M 0.48% 44
2017
Q4
$179M Buy
1,197,351
+169,347
+16% +$25.4M 0.46% 54
2017
Q3
$156M Sell
1,028,004
-170,080
-14% -$25.9M 0.44% 56
2017
Q2
$148M Sell
1,198,084
-83,311
-7% -$10.3M 0.46% 55
2017
Q1
$140M Buy
1,281,395
+159,910
+14% +$17.5M 0.46% 52
2016
Q4
$82.6M Buy
1,121,485
+156,236
+16% +$11.5M 0.31% 93
2016
Q3
$84.2M Buy
965,249
+150,730
+19% +$13.1M 0.32% 88
2016
Q2
$75.9M Buy
814,519
+525,199
+182% +$48.9M 0.3% 90
2016
Q1
$24.7M Sell
289,320
-59,694
-17% -$5.1M 0.11% 221
2015
Q4
$43.9M Buy
349,014
+12,053
+4% +$1.52M 0.19% 142
2015
Q3
$35.1M Sell
336,961
-60,220
-15% -$6.27M 0.15% 173
2015
Q2
$53.6M Buy
397,181
+149,898
+61% +$20.2M 0.22% 115
2015
Q1
$30.5M Buy
247,283
+20,171
+9% +$2.49M 0.13% 214
2014
Q4
$27M Buy
227,112
+74,955
+49% +$8.9M 0.12% 219
2014
Q3
$17.1M Sell
152,157
-127,000
-45% -$14.3M 0.08% 278
2014
Q2
$26.4M Buy
279,157
+31,400
+13% +$2.97M 0.13% 197
2014
Q1
$17.5M Buy
247,757
+7,100
+3% +$502K 0.09% 257
2013
Q4
$17.9M Sell
240,657
-3,300
-1% -$245K 0.09% 245
2013
Q3
$18.5M Buy
243,957
+14,150
+6% +$1.07M 0.1% 226
2013
Q2
$18.4M Buy
+229,807
New +$18.4M 0.11% 207